Literature DB >> 30548162

Local genomic features predict the distinct and overlapping binding patterns of the bHLH-Zip family oncoproteins MITF and MYC-MAX.

Miroslav Hejna1,2, Wooyoung M Moon1,2, Jeffrey Cheng3, Akinori Kawakami4, David E Fisher4, Jun S Song1,2.   

Abstract

MITF and MYC are well-known oncoproteins and members of the basic helix-loop-helix leucine zipper (bHLH-Zip) family of transcription factors (TFs) recognizing hexamer E-box motifs. MITF and MYC not only share the core binding motif, but are also the two most highly expressed bHLH-Zip transcription factors in melanocytes, raising the possibility that they may compete for the same binding sites in select oncogenic targets. Mechanisms determining the distinct and potentially overlapping binding modes of these critical oncoproteins remain uncharacterized. We introduce computational predictive models using local sequence features, including a boosted convolutional decision tree framework, to distinguish MITF versus MYC-MAX binding sites with up to 80% accuracy genomewide. Select E-box locations that can be bound by both MITF and MYC-MAX form a separate class of MITF binding sites characterized by differential sequence content in the flanking region, diminished interaction with SOX10, higher evolutionary conservation, and less tissue-specific chromatin organization.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MITF; MYC-MAX; boosted convolutional decision tree; cobinding factors; machine learning

Mesh:

Substances:

Year:  2018        PMID: 30548162      PMCID: PMC6555698          DOI: 10.1111/pcmr.12762

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  35 in total

1.  GREAT improves functional interpretation of cis-regulatory regions.

Authors:  Cory Y McLean; Dave Bristor; Michael Hiller; Shoa L Clarke; Bruce T Schaar; Craig B Lowe; Aaron M Wenger; Gill Bejerano
Journal:  Nat Biotechnol       Date:  2010-05-02       Impact factor: 54.908

2.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

3.  Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.

Authors:  D L Solomon; B Amati; H Land
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

4.  Differential analysis of gene regulation at transcript resolution with RNA-seq.

Authors:  Cole Trapnell; David G Hendrickson; Martin Sauvageau; Loyal Goff; John L Rinn; Lior Pachter
Journal:  Nat Biotechnol       Date:  2012-12-09       Impact factor: 54.908

5.  Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF.

Authors:  Vivian Pogenberg; Margrét H Ogmundsdóttir; Kristín Bergsteinsdóttir; Alexander Schepsky; Bengt Phung; Viktor Deineko; Morlin Milewski; Eiríkur Steingrímsson; Matthias Wilmanns
Journal:  Genes Dev       Date:  2012-12-01       Impact factor: 11.361

6.  Myc and Max proteins possess distinct transcriptional activities.

Authors:  L Kretzner; E M Blackwood; R N Eisenman
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

7.  Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc.

Authors:  A Shrivastava; S Saleque; G V Kalpana; S Artandi; S P Goff; K Calame
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

8.  Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo.

Authors:  F Fisher; D H Crouch; P S Jayaraman; W Clark; D A Gillespie; C R Goding
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

9.  Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition.

Authors:  Dan E Webster; Brook Barajas; Rose T Bussat; Karen J Yan; Poornima H Neela; Ross J Flockhart; Joanna Kovalski; Ashley Zehnder; Paul A Khavari
Journal:  Genome Res       Date:  2014-01-17       Impact factor: 9.043

10.  YY1 regulates melanocyte development and function by cooperating with MITF.

Authors:  Juying Li; Jun S Song; Robert J A Bell; Thanh-Nga T Tran; Rizwan Haq; Huifei Liu; Kevin T Love; Robert Langer; Daniel G Anderson; Lionel Larue; David E Fisher
Journal:  PLoS Genet       Date:  2012-05-03       Impact factor: 5.917

View more
  5 in total

Review 1.  Compartmentalization and regulation of GTP in control of cellular phenotypes.

Authors:  David W Wolff; Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Trends Mol Med       Date:  2022-06-16       Impact factor: 15.272

2.  Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution.

Authors:  Jacob R Leistico; Priyanka Saini; Christopher R Futtner; Miroslav Hejna; Yasuhiro Omura; Pritin N Soni; Poorva Sandlesh; Magdy Milad; Jian-Jun Wei; Serdar Bulun; J Brandon Parker; Grant D Barish; Jun S Song; Debabrata Chakravarti
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.995

3.  MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.

Authors:  Temesgen D Fufa; Laura L Baxter; Julia C Wedel; Derek E Gildea; Stacie K Loftus; William J Pavan
Journal:  Epigenetics Chromatin       Date:  2019-08-09       Impact factor: 4.954

Review 4.  MITF-the first 25 years.

Authors:  Colin R Goding; Heinz Arnheiter
Journal:  Genes Dev       Date:  2019-05-23       Impact factor: 11.361

5.  Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution.

Authors:  Pakavarin Louphrasitthiphol; Robert Siddaway; Alessia Loffreda; Vivian Pogenberg; Hans Friedrichsen; Alexander Schepsky; Zhiqiang Zeng; Min Lu; Thomas Strub; Rasmus Freter; Richard Lisle; Eda Suer; Benjamin Thomas; Benjamin Schuster-Böckler; Panagis Filippakopoulos; Mark Middleton; Xin Lu; E Elizabeth Patton; Irwin Davidson; Jean-Philippe Lambert; Matthias Wilmanns; Eiríkur Steingrímsson; Davide Mazza; Colin R Goding
Journal:  Mol Cell       Date:  2020-06-11       Impact factor: 17.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.